Ma Ai Thanda Han
Ma Ai Thanda Han
Mayo Clinic, Rochester, MN
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
C Koh, L Canini, H Dahari, X Zhao, SL Uprichard, V Haynes-Williams, ...
The Lancet Infectious Diseases 15 (10), 1167-1174, 2015
1752015
Rates of and factors associated with placebo response in trials of pharmacotherapies for nonalcoholic steatohepatitis: systematic review and meta-analysis
MAT Han, O Altayar, S Hamdeh, V Takyar, Y Rotman, O Etzion, ...
Clinical Gastroenterology and Hepatology 17 (4), 616-629. e26, 2019
462019
Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease
AM Gharib, MAT Han, EG Meissner, DE Kleiner, X Zhao, M McLaughlin, ...
BioMed research international 2017, 2017
312017
Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD)
MAT Han, R Saouaf, W Ayoub, T Todo, E Mena, M Noureddin
Expert review of clinical pharmacology 10 (4), 379-390, 2017
252017
The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection
EC Townsend, GY Zhang, R Ali, M Firke, MS Moon, MAT Han, B Fram, ...
Journal of gastroenterology and hepatology 34 (4), 764-775, 2019
72019
392 Post-Infectious Irritable Bowel Syndrome in Patients Undergoing Fecal Microbiota Transplantation for Recurrent Clostridium difficile Colitis
S Garg, Y Song, MAT Han, M Girotra, WF Fricke, S Dutta
Gastroenterology 146 (5), S-83-S-84, 2014
72014
MR elastography‐based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study
MAT Han, A Vipani, N Noureddin, K Ramirez, J Gornbein, R Saouaf, ...
Liver International 40 (9), 2242-2251, 2020
62020
Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection
L Canini, C Koh, SJ Cotler, SL Uprichard, MA Winters, MAT Han, ...
Hepatology communications 1 (4), 288-292, 2017
52017
Diversity in NAFLD: a review of manifestations of nonalcoholic fatty liver disease in different ethnicities globally
MAT Han, Q Yu, Z Tafesh, N Pyrsopoulos
Journal of Clinical and Translational Hepatology 9 (1), 71, 2021
32021
A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C
C Koh, P Dubey, MAT Han, PJ Walter, HM Garraffo, P Surana, ...
Antiviral research 163, 149-155, 2019
32019
Noninvasive tests (NITs) for hepatic fibrosis in fatty liver syndrome
MAT Han
Life 10 (9), 198, 2020
22020
Accounting for the Placebo Effect and Optimizing Outcomes in Clinical Trials of Nonalcoholic Steatohepatitis (NASH)
N Noureddin, MAT Han, N Alkhouri, M Noureddin
Current Hepatology Reports 19 (1), 63-69, 2020
22020
Liver Functional Assessment by Dual Cholate Testing Is Strongly Correlated with Direct Portal Pressure and Ishak Fibrosis Stage
O Etzion, R Ali, GY Zhang, EC Townsend, C Koh, E Levy, VK Takyar, ...
Hepatology 66, 1036A-1037A, 2017
22017
Modeling hepatitis delta virus dynamics during ritonavir boosted lonafarnib treatment-the LOWR HDV-3 study
P Dubey, C Koh, P Surana, SL Uprichard, MAT Han, N Fryzek, D Kapuria, ...
Hepatology 66, 21A-21A, 2017
22017
Fibrosis changes in the placebo arm of NASH clinical trials
O Altayar, N Noureddin, MAT Han, MH Murad, M Noureddin
Clinical Gastroenterology and Hepatology 17 (11), 2387, 2019
12019
The performance of MRI-proton density fat fraction (PDFF) and MR elastography (MRE) in diagnosing nonalcoholic steatohepatitis (NASH) noninvasively
M Noureddin, V Sundaram, WS Ayoub, MAT Han, JF Grotts, R Saouaf, ...
Hepatology 68, 1327A-1328A, 2018
12018
Abnormal liver tests are inaccurate for diagnosis of chronic hepatic graft versus host disease in critically ill patients
MAT Han, N Samala, BS Rizvi, O Etzion, EC Wright, R Patel, ...
Hepatology 64, 182A-182A, 2016
12016
Liver Involvement in Turner's Syndrome, Is Associated with Extra Hepatic Disease Manifestations: 1720
O Etzion, T Heller, M Han, R Patel, C Koh, D Kleiner, O Mousa, R Loomba, ...
Hepatology 62, 2015
12015
Liver Enzymes Elevation In The Setting Of Chronic Graft-Versus-Host Disease Is A Non Specific Marker Of Inflammation That Does Not Accurately Predict Disease Related Hepatic …
M Han, N Samala, B Rizvi, K Wilkins, O Etzion, E Jones, C Koh, D Kleiner, ...
Hepatology 62, 2015
12015
An Innovative Approach to Resident Scheduling: Use of a Point-Based System to Account for Resident Preferences
RTP Chow, S Tamhane, M Zhang, LA Fisher, J Yoon, S Sehgal, ...
Journal of graduate medical education 7 (3), 451, 2015
12015
The system can't perform the operation now. Try again later.
Articles 1–20